-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics Chief Scientific Officer Joseph P. Lyssikatos Reports Disposal of Common Shares

Reuters·01/22/2026 22:35:15

Please log in to view news